• Company
• Oral contraceptive market expands
• by Whang, byung-woo Dec 23, 2024 04:19pm

• Company
• Multidisciplinary approach required for urothelial carcinoma
• by Whang, byung-woo Dec 23, 2024 05:50am

• Company
• Takeda's Firazyr reimbursable up to four doses per Rx
• by Whang, byung-woo Dec 23, 2024 05:49am

• Company
• LG Chem wins Zemiglo patent dispute
• by Kim, Jin-Gu Dec 20, 2024 05:46am

• Company
• 'Vyloy' to expand treatment options for gastric cancer
• by Whang, byung-woo Dec 19, 2024 05:52am

• Company
• Kuhnil signs licensing agreement with Mochida
• by Whang, byung-woo Dec 18, 2024 05:55am

• Company
• Celltrion launches subsidiary 'BioSolutions' for CDMO
• by Cha Jihyun Dec 18, 2024 05:55am

• Company
• Numerous K-Bio drugs secure FDA ODD
• by Son, Hyung Min Dec 18, 2024 05:55am

• Company
• SK Plasma will exclusively distribute Janssen’s Velcade
• by Nho, Byung Chul Dec 17, 2024 05:51am

• Company
• Celltrion receives CHMP positive opinion for 4 biosimilars
• by Chon, Seung-Hyun Dec 17, 2024 05:51am